<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
U.S. Diagnostic, Inc.
- -------------------------------------------------------------------------------
(Name of issuer)
Common Stock, $.01 par value
- -------------------------------------------------------------------------------
(Title of class of security)
90328Q108
- -------------------------------------------------------------------------------
(CUSIP number)
Robert C. Fanch
Fanch Communications, Inc.
1873 South Bellaire Street, Suite 1550
Denver, Colorado 80222
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
December 29, 1999
- -------------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. ___
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 pages
<PAGE> 2
Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Robert C. Fanch Revocable Trust, Robert C. Fanch, Trustee
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
Not Applicable (b) [ ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
1,755,300
NUMBER OF -------------------------------------------------------
SHARES 8. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
EACH -------------------------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON
WITH: 1,755,300
-------------------------------------------------------
10. SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,755,300
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
Not Applicable
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.72%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
OO (Revocable Trust)
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
Item 1. Title and Class of Securities:
Common Stock, $.01 par value
Name of Issuer: U.S. Diagnostic, Inc.
Address of Issuer's Principal Executive Offices:
777 South Flagler Drive, Suite 1201 East
West Palm Beach, FL 33401
Item 2. Identity and Background:
Item 2(a). Name of Person Filing:
The Robert C. Fanch Revocable Trust
Item 2(b). Address of Principal Business Office or, if None, Residence:
1873 South Bellaire Street, Suite 1550, Denver, Colorado 80222
Item 2(c). Chairman and Chief Executive Officer of Fanch
Communications, Inc.
Item 2(d). No
Item 2(e). No
Item 2(f). Citizenship:
N/A (Colorado Trust); Trustee is US citizen
Item 2(d). Title of Class of Securities:
Common Stock, par value $.01
Item 2(e). CUSIP Number:
90832Q108
Item 3. Source and Amount of Funds:
Personal Funds
$3,211,000
Item 4. Purpose of Transaction.
Investment Only. No Plans.
(a) Not Applicable
(b) Not Applicable
(c) Not Applicable
(d) Not Applicable
(e) Not Applicable
(f) Not Applicable
(g) Not Applicable
(h) Not Applicable
<PAGE> 4
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 2000
_________________________________
Date
/s/ Robert C. Fanch
_________________________________
Signature
Robert C. Fanch/Trustee
_________________________________
Name/Title
